NexImmune Inc. Gains 73.83%
Mon, Jan 29, 2024 at 07:16 PM
NexImmune Inc. (NEXI:NASDAQ) shot up at $9.3, a gain of 73.8%. On Mon, Jan 29, 2024, NEXI:NASDAQ hit a New 2-Week Intraday High of $11.6. From Tue, Jan 16, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Tue, Jan 09, 2024 at $16.57 with a volume of 16M+.
About NexImmune Inc. (NEXI:NASDAQ)
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.
Top 10 Gainers:
- OneMedNet Corp. (ONMD:NASDAQ), 156.27%
- Palisade Bio Inc. (PALI:NASDAQ), 83.21%
- FibroGen, Inc. (FGEN:NASDAQ), 82.71%
- NexImmune Inc. (NEXI:NASDAQ), 73.83%
- Vinco Ventures Inc. (BBIG:NASDAQ), 55%
- Rail Vision Ltd. (RVSN:NASDAQ), 54.63%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 43.69%
- View Inc. (VIEW:NASDAQ), 41.03%
- Selina Hospitality PLC (SLNA:NASDAQ), 38.04%
- Atreca, Inc. (BCEL:NASDAQ), 35.7%